CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $70,369,463
- in 12 filings, $45.5M under 10b5-1 plans
Net −$70,369,463. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-27 | Ramaswamy Vivek 10% owner | Option exercise · Capped Value Appreciation Rights | −203,798 | $6.40 | $1.3M | 7,744,314 |
| 2023-09-27 | Ramaswamy Vivek 10% owner | Option exercise · Capped Value Appreciation Rights | −251,539 | $11.50 | $2.9M | 11,822,307 |
| 2023-09-27 | Kumar Rakhi Chief Accounting Officer | Option exercise | +169 | 196,716 | ||
| 2023-09-27 | Kumar Rakhi Chief Accounting Officer | Option exercise · Capped Value Appreciation Rights | −1,894 | $11.50 | $22K | 80,020 |
| 2023-09-22 | Venker Eric President & COO | Other disposition | −16,416 | $10.19 | $167K | 595,397 |
| 2023-09-22 | Kumar Rakhi Chief Accounting Officer | Other disposition | −1,403 | $10.19 | $14K | 196,547 |
| 2023-09-22 | Gline Matthew CEO | Other disposition | −11,227 | $10.19 | $114K | 1,033,721 |
| 2022-10-16 | MOMTAZEE JAMES C Director | Grant or award 10b5-1 | +1,594 | 75,456 |
Page 38 of 38 · 748 trades